Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Quarterhill Reaches Favorable Mediation Agreement, Strengthening Tolling Contract

(QTRH) TORONTO, Sept. 2, 2025 /PRNewswire/ - Quarterhill Inc. ("Quarterhill" or the "Company") (TSX: QTRH) (OTCQX: QTRHF), a leading global provider of intelligent transportation system ("ITS") sol...

How does this resolution compare to similar contract renegotiations in the ITS sector, and what could it mean for Quarterhill's competitive positioning and stock valuation? What are the specific terms of the new agreement, and how might they impact the company's cost structure and profit margins going forward? How will the mediation agreement and strengthened tolling contract affect Quarterhill's revenue forecasts and cash flow outlook?
Symbol: QTRH
Legal
14 days ago
Read more prnewswire

Nova Announces Proposed Private Offering of $500 Million of 0.00% Convertible Senior Notes due 2030

(NASDAQ:NVMI) REHOVOT, Israel, Sept. 2, 2025 /PRNewswire/ -- Nova (NASDAQ: NVMI), a leading innovator and a key provider of advanced metrology and process control solutions used in semiconductor ma...

At what price and yield are the notes being offered, and how does this compare to current market rates for similar zero‑coupon securities? What are the conversion terms and expected dilution for existing shareholders if the notes are converted into common equity? How will the $500 million convertible senior notes issuance affect Nova's capital structure and leverage ratios?
Symbol: NVMI
Debt
14 days ago
Read more prnewswire

Equity Bancshares, Inc. Enters Nebraska, Acquires Frontier Holdings, LLC

(NYSE:EQBK) WICHITA, Kan.--(BUSINESS WIRE)-- #EquityBankUSA--Equity Bancshares, Inc. (NYSE: EQBK), (“Equity”, “the Company,” “we,” “us,” “our”), the Wichita-based holding company of Equity Bank, an...

Are there any regulatory or integration risks that could delay or affect the expected synergies from the Frontier Bank merger? What impact will the addition of seven Nebraska locations have on the company's regional market share and deposit growth? How will the acquisition affect Equity Bancshares' earnings per share forecasts and valuation multiples?
Symbol: EQBK
Mergers
14 days ago
Read more businesswire

Stoke Therapeutics and Biogen Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome

(NASDAQ:BIIB) BEDFORD, Mass. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s...

How might this partnership with Stoke Therapeutics influence Biogen's pipeline diversification and competitive positioning in the rare neurological space? What are the potential regulatory timelines and market exclusivity for a disease‑modifying therapy in Dravet syndrome compared to existing treatments? How will the Phase 1/2a results for zorevunersen affect Biogen's valuation and upcoming earnings guidance?
Symbol: BIIB
Clinical trials
14 days ago
Read more businesswire

BLP Expands National Footprint with 1.56M SF Atlanta Acquisition, Underscoring Conviction Amid Market Volatility

(NYSE:BRDG) ATLANTA--(BUSINESS WIRE)-- #atlanta--Bridge Logistics Properties (“BLP”), a subsidiary of Bridge Investment Group Holdings Inc. (NYSE: BRDG) (“Bridge”), today announced the acquisition ...

Will the increased exposure to the Atlanta logistics hub improve BRDG's geographic diversification and risk profile amid current tariff volatility and macroeconomic uncertainty? What is the valuation multiple (price per square foot) for this deal compared to recent comparable Class A industrial acquisitions in the Atlanta market and to peers such as Prologis and Duke Realty? How will the $1.56M sq ft Atlanta acquisition affect Bridge Logistics Properties' (BRDG) earnings per share and cash flow outlook?
Symbol: BRDG
Mergers
14 days ago
Read more businesswire

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

(NASDAQ:PLSE) HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) t...

How does Pulse Biosciences' nanosecond PFA technology compare to existing treatments for benign thyroid nodules and any competitive threats? What is the expected timeline for additional data releases or potential FDA clearance for the nsPFA™ system in thyroid indications? How will the successful first procedures in the PRECISE-BTN study affect Pulse Biosciences' short‑term stock performance?
Symbol: PLSE
Clinical trials
14 days ago
Read more businesswire